New Delhi, Oct. 7 -- Eli Lilly, the U.S.-based pharmaceutical giant, has announced plans to invest over $1 billion in India over the coming years.

This move aims to strengthen contract manufacturing and supply chain capabilities through partnerships with local drugmakers.

A major part of this investment will be the establishment of a new manufacturing and global medicine supply hub in Hyderabad. The facility will serve as a central point to oversee and enhance Lilly's contract manufacturing network across India, supporting the production of essential medicines for various conditions.

Patrik Jonsson, President of Lilly International, said the initiative highlights the company's commitment to expanding global manufacturing capacity and e...